[{"indications": "Indications\u00a0status epilepticus; other\r\nforms of epilepsy, and myoclonus (section 4.8.1)", "name": "CLONAZEPAM - DRUGS USED IN STATUS EPILEPTICUS", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "4 Central nervous system", "4.8 Antiepileptic drugs", "4.8.2 Drugs used in status epilepticus", "CLONAZEPAM"], "cautions": "Cautions\u00a0see Clonazepam, section 4.8.1; facilities for\r\nreversing respiratory depression with mechanical ventilation must\r\nbe at hand (but see also notes above) ", "side-effects": "Side-effects\u00a0see Clonazepam, section 4.8.1; hypotension\r\nand apnoea", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/9934.htm", "doses": ["By intravenous injection into a large vein\r\n(over at least 2 minutes), 1\u00a0mg, repeated if necessary; child all ages, 500\u00a0micrograms"], "pregnancy": "Pregnancy\u00a0see Benzodiazepines, section 4.1.2, and Pregnancy"}, {"indications": "Indications\u00a0all forms of epilepsy; myoclonus; status epilepticus\r\n(section 4.8.2)", "name": "CLONAZEPAM", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "4 Central nervous system", "4.8 Antiepileptic drugs", "4.8.1 Control of the epilepsies", "Benzodiazepines"], "cautions": "Cautions\u00a0\n(From 4.8.1 Control of the epilepsies: British National Formulary)\n4.8.1 Control of the epilepsies; elderly and debilitated patients, respiratory disease, spinal or cerebellar\r\nataxia; history of alcohol or drug abuse, depression\r\nor suicidal ideation; avoid sudden withdrawal; myasthenia gravis (avoid if unstable); acute porphyria (%s\n(From 9.8.2 Acute porphyrias: British National Formulary)\n9.8.2 Acute porphyrias); interactions: Appendix 1 (anxiolytics and hypnotics)Driving\u00a0Drowsiness may affect performance\r\nof skilled tasks (e.g. driving); effects\r\nof alcohol enhanced", "side-effects": "Side-effects\u00a0drowsiness, fatigue, dizziness,\r\nmuscle hypotonia, co-ordination disturbances; also poor concentration,\r\nrestlessness, confusion, amnesia, dependence, and withdrawal; salivary\r\nor bronchial hypersecretion in infants and small children; rarely gastro-intestinal symptoms, respiratory depression,\r\nheadache, paradoxical effects including aggression and anxiety, sexual\r\ndysfunction,  urinary incontinence, urticaria, pruritus, reversible\r\nhair loss, skin pigmentation changes; dysarthria, and visual disturbances\r\non long-term treatment; blood disorders reported; suicidal ideation; overdosage: see Emergency Treatment of Poisoning", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/3607.htm", "doses": ["1\u00a0mg (elderly 500\u00a0micrograms)\r\ninitially at night for 4 nights, increased according to response over\r\n2\u20134 weeks to usual maintenance dose of 4\u20138\u00a0mg usually at night (may\r\nbe given in 3\u20134 divided doses if necessary); child up to 1 year, initially 250\u00a0micrograms increased as above to usual\r\nmaintenance dose of 0.5\u20131\u00a0mg, 1\u20135 years, initially 250\u00a0micrograms\r\nincreased as above to 1\u20133\u00a0mg, 5\u201312 years, initially 500\u00a0micrograms\r\nincreased as above to 3\u20136\u00a0mg", "Clonazepam doses in BNF may differ from those\r\nin product literature"], "pregnancy": "Pregnancy\u00a0see Benzodiazepines, section 4.1.2"}, {"indications": "Indications\u00a0all forms of epilepsy; myoclonus; status epilepticus\r\n(section 4.8.2)", "name": "CLONAZEPAM - BENZODIAZEPINES", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "4 Central nervous system", "4.8 Antiepileptic drugs", "4.8.1 Control of the epilepsies", "Benzodiazepines"], "cautions": "Cautions\u00a0\n(From 4.8.1 Control of the epilepsies: British National Formulary)\n4.8.1 Control of the epilepsies; elderly and debilitated patients, respiratory disease, spinal or cerebellar\r\nataxia; history of alcohol or drug abuse, depression\r\nor suicidal ideation; avoid sudden withdrawal; myasthenia gravis (avoid if unstable); acute porphyria (%s\n(From 9.8.2 Acute porphyrias: British National Formulary)\n9.8.2 Acute porphyrias); interactions: Appendix 1 (anxiolytics and hypnotics)Driving\u00a0Drowsiness may affect performance\r\nof skilled tasks (e.g. driving); effects\r\nof alcohol enhanced", "side-effects": "Side-effects\u00a0drowsiness, fatigue, dizziness,\r\nmuscle hypotonia, co-ordination disturbances; also poor concentration,\r\nrestlessness, confusion, amnesia, dependence, and withdrawal; salivary\r\nor bronchial hypersecretion in infants and small children; rarely gastro-intestinal symptoms, respiratory depression,\r\nheadache, paradoxical effects including aggression and anxiety, sexual\r\ndysfunction,  urinary incontinence, urticaria, pruritus, reversible\r\nhair loss, skin pigmentation changes; dysarthria, and visual disturbances\r\non long-term treatment; blood disorders reported; suicidal ideation; overdosage: see Emergency Treatment of Poisoning", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/3607.htm", "doses": ["1\u00a0mg (elderly 500\u00a0micrograms)\r\ninitially at night for 4 nights, increased according to response over\r\n2\u20134 weeks to usual maintenance dose of 4\u20138\u00a0mg usually at night (may\r\nbe given in 3\u20134 divided doses if necessary); child up to 1 year, initially 250\u00a0micrograms increased as above to usual\r\nmaintenance dose of 0.5\u20131\u00a0mg, 1\u20135 years, initially 250\u00a0micrograms\r\nincreased as above to 1\u20133\u00a0mg, 5\u201312 years, initially 500\u00a0micrograms\r\nincreased as above to 3\u20136\u00a0mg", "Clonazepam doses in BNF may differ from those\r\nin product literature"], "pregnancy": "Pregnancy\u00a0see Benzodiazepines, section 4.1.2"}]